Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 10:14 am Purchase | 2025-12-31 | 13G | Oragenics, Inc. OGEN | SABBY MANAGEMENT LLC | 412,654 9.900% | 412,654 (New Position) | Filing History |
| 2026-01-21 09:27 am Purchase | 2025-12-31 | 13G | Tempest Therapeutics, Inc. TPST | SABBY MANAGEMENT LLC | 492,223 9.900% | 492,223 (New Position) | Filing History |
| 2026-01-21 08:58 am Unchanged | 2025-12-31 | 13G | Jiuzi Holdings, Inc. JZXN | SABBY MANAGEMENT LLC | 206,273 9.900% | 0 (Unchanged) | Filing History |
| 2026-01-21 08:44 am Purchase | 2025-12-31 | 13G | Globavend Holdings Limited GVH | SABBY MANAGEMENT LLC | 211,464 9.900% | 211,464 (New Position) | Filing History |
| 2026-01-21 07:54 am Purchase | 2025-12-31 | 13G | FOXO Technologies Inc. FOXO | SABBY MANAGEMENT LLC | 249,316,528 9.900% | 249,316,528 (New Position) | Filing History |
| 2026-01-20 8:31 pm Purchase | 2025-12-31 | 13G | Revelation Biosciences, Inc. REVB | SABBY MANAGEMENT LLC | 151,426 9.600% | 151,426 (New Position) | Filing History |
| 2026-01-20 7:54 pm Purchase | 2025-12-31 | 13G | Nuwellis, Inc. NUWE | SABBY MANAGEMENT LLC | 89,685 5.400% | 89,685 (New Position) | Filing History |
| 2026-01-20 7:18 pm Purchase | 2025-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | SABBY MANAGEMENT LLC | 175,158 9.900% | 175,158 (New Position) | Filing History |
| 2026-01-20 3:14 pm Purchase | 2025-12-31 | 13G | Jiuzi Holdings, Inc. JZXN | SABBY MANAGEMENT LLC | 206,273 9.900% | 206,273 (New Position) | Filing History |
| 2026-01-20 2:25 pm Purchase | 2025-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 280,138 9.900% | 280,138 (New Position) | Filing History |
| 2026-01-20 1:49 pm Purchase | 2025-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | SABBY MANAGEMENT LLC | 217,600 9.900% | 217,600 (New Position) | Filing History |
| 2026-01-20 12:48 pm Purchase | 2025-12-31 | 13G | Big Tree Cloud Holdings Limited DSY | SABBY MANAGEMENT LLC | 288,499 6.600% | 288,499 (New Position) | Filing History |
| 2026-01-07 3:37 pm Purchase | 2025-12-31 | 13G | Universe Pharmaceuticals Inc. UPC | SABBY MANAGEMENT LLC | 28,111 4.900% | 28,111 (New Position) | Filing History |
| 2026-01-07 3:05 pm Purchase | 2025-12-31 | 13G | Empery Digital Inc. EMPD | SABBY MANAGEMENT LLC | 479,428 1.300% | 479,428 (New Position) | Filing History |
| 2026-01-07 2:19 pm Purchase | 2025-12-31 | 13G | BNB Plus Corp. BNBX | SABBY MANAGEMENT LLC | 217,840 4.900% | 217,840 (New Position) | Filing History |
| 2026-01-07 12:38 pm Purchase | 2025-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | SABBY MANAGEMENT LLC | 41,601 4.900% | 41,601 (New Position) | Filing History |
| 2026-01-07 12:03 pm Purchase | 2025-12-31 | 13G | Cyngn Inc. CYN | SABBY MANAGEMENT LLC | 77,680 1.000% | 77,680 (New Position) | Filing History |
| 2025-01-03 8:51 pm Purchase | 2024-12-31 | 13G | Universe Pharmaceuticals Inc. UPC | SABBY MANAGEMENT LLC | 18,180 9.900% | 18,180 (New Position) | Filing History |
| 2025-01-03 8:18 pm Purchase | 2024-12-31 | 13G | Empery Digital Inc. EMPD | SABBY MANAGEMENT LLC | 56,034 9.900% | 56,034 (New Position) | Filing History |
| 2025-01-03 7:50 pm Purchase | 2024-12-31 | 13G | Applied DNA Sciences, Inc. APDN | SABBY MANAGEMENT LLC | 6,966 10.000% | 6,966 (New Position) | Filing History |